BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25908007)

  • 1. [Uveitic macular edema and the pharmacotherapy].
    Liu X; Zhang M
    Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):151-4. PubMed ID: 25908007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update in treatment of uveitic macular edema.
    Koronis S; Stavrakas P; Balidis M; Kozeis N; Tranos PG
    Drug Des Devel Ther; 2019; 13():667-680. PubMed ID: 30858697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.
    Tsui E; Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Balamurugan S; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan J; Ebert CD; Kim E; Madow B; Porco TC; Acharya NR;
    Ophthalmology; 2022 Jun; 129(6):661-667. PubMed ID: 35143800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema.
    Sreekantam S; Denniston AK; Murray PI
    Ocul Immunol Inflamm; 2011 Oct; 19(5):353-7. PubMed ID: 21823935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal Antiangiogenic Therapy of Uveitic Macular Edema: A Review.
    Kozak I; Shoughy SS; Stone DU
    J Ocul Pharmacol Ther; 2017 May; 33(4):235-239. PubMed ID: 28165851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical review: Update on treatment of inflammatory macular edema.
    Ossewaarde-van Norel A; Rothova A
    Ocul Immunol Inflamm; 2011 Feb; 19(1):75-83. PubMed ID: 21034302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic non-infectious uveitis and scleritis.
    Rossi DC; Ribi C; Guex-Crosier Y
    Swiss Med Wkly; 2019 Feb; 149():w20025. PubMed ID: 30852832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local therapeutic options for uveitic cystoid macular edema.
    Slean GR; Khurana RN
    Int Ophthalmol Clin; 2015; 55(3):39-61. PubMed ID: 26035761
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.
    Rathinam SR; Babu M; Thundikandy R; Kanakath A; Nardone N; Esterberg E; Lee SM; Enanoria WT; Porco TC; Browne EN; Weinrib R; Acharya NR
    Ophthalmology; 2014 Oct; 121(10):1863-70. PubMed ID: 24917273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil in the therapy of uveitic macular edema--long-term results.
    Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Deuter C
    Ocul Immunol Inflamm; 2012 Jun; 20(3):203-11. PubMed ID: 22489750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol.
    Tallouzi MO; Moore DJ; Calvert M; Murray PI; Bucknall N; Denniston AK
    Syst Rev; 2016 Feb; 5():29. PubMed ID: 26872918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystoid macular edema in uveitis].
    Thurau SR
    Ophthalmologe; 2005 May; 102(5):485-90. PubMed ID: 15747121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab and macular edema.
    Kumar A
    Ophthalmology; 2008 Mar; 115(3):585. PubMed ID: 18319106
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy.
    Kiss S; Ahmed M; Letko E; Foster CS
    Ophthalmology; 2005 Jun; 112(6):1066-71. PubMed ID: 15936442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis.
    Muselier A; Bielefeld P; Bidot S; Vinit J; Besancenot JF; Bron A
    Ocul Immunol Inflamm; 2011 Oct; 19(5):382-3. PubMed ID: 21970668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic management of autoimmune anterior uveitis].
    Bachta A; TÅ‚ustochowicz M
    Klin Oczna; 2005; 107(10-12):710-4. PubMed ID: 16619827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab for treatment of uveitic macular edema.
    Cordero Coma M; Sobrin L; Onal S; Christen W; Foster CS
    Ophthalmology; 2007 Aug; 114(8):1574-1579.e1. PubMed ID: 17363060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveitic macular edema.
    Fardeau C; Champion E; Massamba N; LeHoang P
    Eye (Lond); 2016 Oct; 30(10):1277-1292. PubMed ID: 27256304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Therapy of Uveitic Macular Edema: Biologic Agents.
    Radosavljevic A; Agarwal M; Bodaghi B; Smith JR; Zierhut M
    Ocul Immunol Inflamm; 2020 Nov; 28(8):1239-1250. PubMed ID: 32058830
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment].
    Paire V; Lebreton O; Weber M
    J Fr Ophtalmol; 2010 Mar; 33(3):152-62. PubMed ID: 20181409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.